Insider Trading Activity Charles River Laboratories Intl. Inc (NYSE:CRL) – Chairman Sold 4,967 shares of Stock

ME Staff
-
0

Insider Trading Activity For Charles River Laboratories Intl. Inc (NYSE:CRL)

James C Foster , Chairman of Charles River Laboratories Intl. Inc (NYSE:CRL) reportedly Sold 4,967 shares of the company’s stock at an average price of 109.44 for a total transaction amount of $543,588.48 SEC Form

Insider Trading History For Charles River Laboratories Intl. Inc (NYSE:CRL)

  • On 3/13/2013 David P Johst, VP, sold 17,038 with an average share price of $45.00 per share and the total transaction amounting to $766,710.00.View SEC Filing
  • On 5/10/2013 George Massaro, Director, sold 2,020 with an average share price of $44.09 per share and the total transaction amounting to $89,061.80.View SEC Filing
  • On 5/14/2013 James C Foster, CEO, sold 113,810 with an average share price of $45.00 per share and the total transaction amounting to $5,121,450.00.View SEC Filing
  • On 6/3/2013 Thomas F Ackerman, CFO, sold 4,000 with an average share price of $42.40 per share and the total transaction amounting to $169,600.00.View SEC Filing
  • On 8/2/2013 Thomas Ackerman, CFO, sold 26,250 with an average share price of $46.03 per share and the total transaction amounting to $1,208,287.50.View SEC Filing
  • On 8/2/2013 Deborah Turner Kochevar, Director, sold 4,447 with an average share price of $46.02 per share and the total transaction amounting to $204,650.94.View SEC Filing
  • On 8/2/2013 Davide Molho, VP, sold 4,100 with an average share price of $45.89 per share and the total transaction amounting to $188,149.00.View SEC Filing

    • Analyst Ratings History For Charles River Laboratories Intl. Inc (NYSE:CRL)

    • On 1/7/2016 Wells Fargo & Co Upgraded rating Market Perform to Outperform
    • On 2/11/2016 Deutsche Bank Reiterated Rating Hold with a price target of $85.00 to $82.00
    • On 4/26/2016 Gabelli Initiated Coverage of rating Buy with a price target of $96.00
    • On 5/22/2016 KeyCorp Reiterated Rating Hold with a price target of $77.00
    • On 12/16/2016 Goldman Sachs Group Upgraded rating Sell to Neutral with a price target of $75.00 to $77.00
    • On 1/4/2017 Evercore ISI Upgraded rating Hold to Buy with a price target of $86.50
    • On 6/28/2017 Citigroup Reiterated Rating Neutral with a price target of $91.00 to $104.00

    Recent Trading Activity for Charles River Laboratories Intl. Inc (NYSE:CRL)
    Shares of Charles River Laboratories Intl. Inc closed the previous trading session at 110.34 up +0.03 0.03% with shares trading hands.